Table 8. Comparison of clinical laboratory values and lesion severity score.
| Total Lesion Severity Score | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test | <25 (N = 20) |
25–99 (N = 58) |
100–499 (N = 91) |
> = 500 (N = 47) |
Adjusted P value | Raw P value | ||||
| n | Median (Min-Max) | n | Median (Min-Max) | n | Median (Min-Max) | n | Median (Min-Max) | |||
| ALB (G/DL) | 20 | 2.90 (2.1–7.7) | 54 | 2.80 (1.3–3.3) | 86 | 2.70 (1.5–3.7) | 46 | 2.60 (1.9–3.5) | 0.1366 | 0.0137 |
| ALP (U/L) | 20 | 107.0 (1–238) | 54 | 115.5 (47–242) | 84 | 114.5 (57–238) | 44 | 107.5 (48–304) | 1.0000 | 0.3541 |
| ALT (U/L) | 20 | 24.0 (3–43) | 54 | 21.0 (7–59) | 86 | 24.0 (6–174) | 46 | 21.0 (3–201) | 1.0000 | 0.4744 |
| AMY (U/L) | 20 | 72.0 (25–200) | 54 | 65.0 (8–161) | 86 | 65.0 (6–1061) | 45 | 43.0 (3–215) | 0.1123 | 0.0102 |
| AST (U/L) | 20 | 38.0 (23–87) | 54 | 36.5 (9–171) | 86 | 39.5 (13–282) | 45 | 44.0 (18–865) | 0.3047 | 0.0339 |
| BUN (MG/DL) | 19 | 8.0 (1–14) | 50 | 6.0 (1–13) | 75 | 7.0 (1–19) | 43 | 9.0 (2–32) | 0.0806 | 0.0067 |
| CA (MG/DL) | 20 | 8.80 (2.7–9.3) | 54 | 8.90 (4.2–10.1) | 86 | 9.00 (7.4–9.8) | 45 | 8.90 (7.5–10.2) | 1.0000 | 0.1794 |
| CRE (MG/DL) | 20 | 0.70 (0.4–5.5) | 54 | 0.65 (0.3–1.3) | 84 | 0.60 (0.1–1.4) | 44 | 0.60 (0.1–1.4) | 1.0000 | 0.3254 |
| GGT (U/L) | 20 | 32.0 (15–157) | 54 | 27.0 (3–197) | 86 | 30.5 (7–703) | 46 | 30.0 (11–391) | 1.0000 | 0.6695 |
| GLU (MG/DL) | 20 | 89.5 (63–113) | 54 | 89.5 (53–127) | 86 | 95.0 (41–170) | 46 | 96.5 (60–209) | 0.6767 | 0.0967 |
| TBIL (MG/DL) | 20 | 0.70 (0.5–1.3) | 54 | 0.50 (0.3–1.3) | 86 | 0.60 (0.3–1.2) | 45 | 0.60 (0.3–2.4) | 0.3539 | 0.0442 |
| TP (G/DL) | 20 | 7.60 (6.9–13.0) | 54 | 7.90 (3.2–9.5) | 86 | 7.80 (5.4–9.6) | 46 | 7.65 (6.1–10.1) | 1.0000 | 0.9009 |
Clinical laboratory tests by total lesion severity score on admission day. Statistics performed by Kruskal Wallis Test with stepdown Bonferroni correction.